So far, a positive trend towards OS is suggested in a subset of patients whose tumors express PD-L1 with a CPS greater than or equal to 20.
← all excerpts
Checkpoint Inhibitors in Cancer Therapy: Clinical Benefits for Head and Neck Cancers.
1
—
—
So far, a positive trend towards OS is suggested in a subset of patients whose tumors express PD-L1 with a CPS greater than or equal to 20.